Editorial Board — Medscape Psychiatry & Mental Health
Board Members
- Christoph U. Correll, MD
- Hofstra North Shore Long Island School of Medicine
Hempstead, New York
The Zucker Hillside Hospital
Glen Oaks, New York
- Hofstra North Shore Long Island School of Medicine
- Bradley Gaynes, MD, MPH
- University of North Carolina School of Medicine
Chapel Hill, North Carolina
- University of North Carolina School of Medicine
- Joseph F. Goldberg, MD
- Icahn School of Medicine at Mount Sinai
New York, New York
- Icahn School of Medicine at Mount Sinai
- Eric Hollander, MD
- Albert Einstein College of Medicine
Spectrum Neuroscience and Treatment Institute
New York, NY
- Albert Einstein College of Medicine
- Jeffrey A. Lieberman, MD
- Columbia University
New York State Psychiatric Institute/Columbia University Medical Center
New York, New York
- Columbia University
- Jon McClellan, MD
- University of Washington
Seattle, Washington
Child Study and Treatment Center
Lakewood, Washington
- University of Washington
- Drew Ramsey, MD
- Columbia University
New York, New York
- Columbia University
- Stephen M. Strakowski, MD
- Professor and Chair
Dell Medical School
University of Texas
- Professor and Chair
Board Member Details
Christoph U. Correll, MD
Professor of Psychiatry and Molecular Medicine, Department of Psychiatry; Hofstra North Shore Long Island School of Medicine, Hempstead, New York; Medical Director, Recognition and Prevention Program, The Zucker Hillside Hospital, Glen Oaks, New York
Christoph U. Correll, MD, has disclosed the following relevant financial relationships:
Serve(d) as consultant and/or advisor to or has received honoraria from: Alkermes, Inc; Allergan; Angelini; Gerson Lehrman Group; IntraCellular Therapies; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Johnson & Johnson; LB Pharma; Lundbeck, Inc; Medavante; Medscape; Merck & Co.; Neurocrine; Otsuka Pharmaceutical Co., Ltd.; Pfizer Inc.; ROVI; SERVIER; Sunovion; Takeda Pharmaceuticals North America, Inc.; Teva Neuroscience, Inc.
Serve(d) as a speaker or a member of a speakers bureau for: Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Lundbeck, Inc; Otsuka Pharmaceutical Co., Ltd.; Pfizer Inc.; Sunovion; Takeda Pharmaceuticals North America, Inc.
Received a research grant from: Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Takeda Pharmaceuticals North America, Inc.
Received income in an amount equal to or greater than $250 from: Alkermes, Inc.; Allergan; Angelini; Gerson Lehrman Group; IntraCellular Therapies; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Johnson & Johnson; LB Pharma; Lundbeck, Inc; Medavante; Medscape; Neurocrine; Otsuka Pharmaceutical Co., Ltd.; Pfizer Inc.; ROVI; SERVIER; Sunovion; Takeda Pharmaceuticals North America, Inc.; Teva Neuroscience, Inc.
Bradley Gaynes, MD, MPH
Professor, Department of Psychiatry, Associate Chair of Research Training and Education, University of North Carolina School of Medicine, Chapel Hill, North Carolina
Bradley Gaynes, MD, MPH, has disclosed no relevant financial relationships.
Joseph F. Goldberg, MD
Clinical Professor of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York; Private practice, Norwalk, Connecticut
Joseph F. Goldberg, MD, MS, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Neurocrine; Supernus; Sunovion
Serve(d) as a speaker or a member of a speakers bureau for: Merck & Co., Inc.; Sunovion; Neurocrine; Takeda-Lundbeck
Received royalties from: American Psychiatric Publishing Inc.
Eric Hollander, MD
Professor of Psychiatry & Behavioral Sciences, Albert Einstein College of Medicine, Bronx, New York; Director, Spectrum Neuroscience and Treatment Institute, New York, New York
Eric Hollander, MD, has disclosed the following relevant financial relationships:
Serve(d) as a speaker or member of a speakers bureau for: Sunovion
Received research grant from: Roche; Curemark; Neurocrine Biosciences, Inc.
Jeffrey A. Lieberman, MD
Chairman, Department of Psychiatry, Columbia University; Director, Department of Psychiatry, New York State Psychiatric Institute, New York, New York
Jeffrey A. Lieberman, MD, has disclosed the following relevant financial relationships:
Serve(d) as a consultant or member of the advisory board for: Intra-Cellular Therapies; Eli Lilly and Company; Pierre Fabre; Pear Therapeutics, Inc. (unpaid); PsychoGenics (unpaid)
Received support administered through institution (funding or medical supplies) from: Denovo Biopharma; Taisho Pharmaceutical Co., Ltd.; Pfizer, Inc.; Sunovion Pharmaceuticals Inc.; Genentech, Inc.
Received support administered through institution for company-sponsored phase 2, 3, and 4 studies from: Alkermes, Inc.; Allergan, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.
Received honoraria from: Clintara
Received patent from: Repligen Corporation (no royalties)
Jon McClellan, MD
Professor, Department of Psychiatry, University of Washington, Seattle; Medical Director, Child Study and Treatment Center, Lakewood, Washington
Jon McClellan, MD, has disclosed the following relevant financial relationship:
Received research grant from: National Institutes of Health
Drew Ramsey, MD
Assistant Clinical Professor, Department of Psychiatry, Columbia University, New York, New York
Drew Ramsey, MD, has disclosed the following relevant financial relationships:
Have a 5% or greater equity interest in: Eat to Beat Depression eCourse
Author: Eat Complete; The Happiness Diet; 50 Shades of Kale
Stephen M. Strakowski, MD
Professor and Chair, Dell Medical School, University of Texas, Austin
Stephen M. Strakowski, MD, has disclosed the following relevant financial relationships:
Received research grant from: Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Otsuka Pharmaceutical Co., Ltd. (to employer)
Received income in an amount equal to or greater than $250 from: Sunovion (chair of Data and Safety Monitoring Board); Springer (journal editor)
